Promising pre-clinical data on the next generation drug eluting bioresorbable scaffold

Paris, France, May 21 2015 — Terumo and Arterial Remodeling Technologies (ART) announce that, on May 20, 2015, Dr Renu Virmani, internationally renowned cardiovascular pathologist at CVPath Institute, USA, presented promising pre-clinical data on Terumo’s next generation drug eluting bioresorbable scaffold for the treatment of coronary artery disease.

“We are particularly satisfied with the well balanced drug effect of the drug eluting bioresorbable scaffold, while preserving the competitive bioresorbable properties of the ART scaffold of early programmed dismantling and complete resorption” said Machiel van der Leest, CEO of ART.

 

ART-News 150521